【レポートの概要(一部)】
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Indolent Lymphoma 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Indolent Lymphoma to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Indolent Lymphoma to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Indolent Lymphoma 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Indolent Lymphoma Therapeutics Clinical Trials 30
Prominent Drugs 31
Latest Clinical Trials News on Indolent Lymphoma 32
Jan 22, 2014: New drug shows promise in treating indolent non-Hodgkin lymphomas 32
Dec 10, 2013: Studies Evaluating REVLIMID (Lenalidomide) in Lymphoma Presented at ASH 32
Dec 08, 2013: Gilead Announces Pivotal Phase 2 Data for Idelalisib in Refractory Indolent Non-Hodgkin’s Lymphoma 34
Dec 10, 2012: Infinity Pharma Reports IPI-145 Phase I Data Showing Clinical Activity In B-Cell And T-Cell Malignancies At ASH Annual Meeting 35
Aug 17, 2011: Emergent Announces Initiation Of Phase Ib/II Study Of TRU-016 In Combination With Rituximab And Bendamustine In Subjects With Relapsed-Indolent Lymphoma 36
Clinical Trial Profiles 38
Clinical Trial Overview of Top Companies 38
F. Hoffmann-La Roche Ltd. 38
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 38
Gilead Sciences, Inc. 40
Clinical Trial Overview of Gilead Sciences, Inc. 40
Celgene Corporation 41
Clinical Trial Overview of Celgene Corporation 41
Teva Pharmaceutical Industries Limited 42
Clinical Trial Overview of Teva Pharmaceutical Industries Limited 42
Cell Therapeutics, Inc. 43
Clinical Trial Overview of Cell Therapeutics, Inc. 43
GlaxoSmithKline plc 44
Clinical Trial Overview of GlaxoSmithKline plc 44
Sanofi 45
Clinical Trial Overview of Sanofi 45
Pharmacyclics, Inc. 46
Clinical Trial Overview of Pharmacyclics, Inc. 46
Infinity Pharmaceuticals, Inc. 47
Clinical Trial Overview of Infinity Pharmaceuticals, Inc. 47
Bayer AG 48
Clinical Trial Overview of Bayer AG 48
Clinical Trial Overview of Top Institutes / Government 49
National Cancer Institute 49
Clinical Trial Overview of National Cancer Institute 49
The University of Texas M. D. Anderson Cancer Center 50
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 50
Memorial Sloan Kettering Cancer Center 51
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 51
University of Nebraska 52
Clinical Trial Overview of University of Nebraska 52
Fred Hutchinson Cancer Research Center 53
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 53
Hoag Memorial Hospital Presbyterian 54
Clinical Trial Overview of Hoag Memorial Hospital Presbyterian 54
Massachusetts General Hospital 55
Clinical Trial Overview of Massachusetts General Hospital 55
Beth Israel Deaconess Medical Center 56
Clinical Trial Overview of Beth Israel Deaconess Medical Center 56
Virginia Commonwealth University 57
Clinical Trial Overview of Virginia Commonwealth University 57
Ohio State University Comprehensive Cancer Center 58
Clinical Trial Overview of Ohio State University Comprehensive Cancer Center 58
Five Key Clinical Profiles 59
Appendix 151
Abbreviations 151
Definitions 151
Research Methodology 152
Secondary Research 152
About GlobalData 153
Contact Us 153
Disclaimer 153
Source 154
【レポート販売概要】
■ タイトル:低悪性度リンパ腫:世界の臨床試験レビュー(2014年上半期)■ 英文:Indolent Lymphoma Global Clinical Trials Review, H1, 2014
■ 発行日:2014年2月28日
■ 調査会社:GlobalData
■ 商品コード:GDHC2020CTIDB
■ 調査対象地域:グローバル
- エアゾール噴射剤の世界市場:炭化水素、亜酸化窒素、二酸化炭素、DME、CFCAbout Aerosol Propellant Aerosol propellants comprise two components: aerosols and propellants. Aerosols area mixture of liquid and solid particles suspended in air or gas, whereas propellants are chemicals that generate pressure and push the content out of the container. Aerosol propellants provide a convenient method of dispensing aerosols. They provide a targeted stream, which ensures minimal w …
- 医薬品有効成分(原薬/API)の世界市場About Active Pharmaceutical Ingredients Active pharmaceutical ingredients are the active substances that are used in the manufacture of a drug and have a pharmacological effect. They provide health benefits and play a vital role in disease diagnosis, prevention, and treatment. Active pharmaceutical ingredients may be synthesized either chemically or through biotechnological methods. They are used …
- ヘモグロビン異常症の世界市場規模および予測:タイプ別(アルファサラセミア、ベータサラセミア、鎌状赤血球症、Hb変異体疾患)、治療法別(輸血、鉄キレート療法、骨髄移植、ヒドロキシ尿素)、診断別(血液検査、遺伝子検査、出生前診断、着床前診断、ヘモグロビン電気泳動)、動向分析、2012-2022Global hemoglobinopathies market is expected to reach over USD 8.82 billion by 2022 according to a new report by Grand View Research Inc. Rising prevalence of hemoglobin disorders such as sickle cell anemia, thalassemia, Hb C, and Hb E is estimated to be the high impact rendering drivers of the market. According to the WHO, hemoglobin disorders are endemic in over 60% of 229 countries affecting ov …
- 乾燥スープの世界市場2016-2020About Dried Soup Generally, soups are made by combining ingredients such as meat, vegetables, and water or another liquid and are usually served warm. Soups are classified into two types: clear soup and thick soup. Soup is considered to be as old as the history of cooking. Soups served as the foundation for the first public restaurants in Paris in the 18th century. Soup is a heterogeneous food cat …
- 電子飛行計器システム(EFIS)の世界市場予測(~2021):用途別(飛行、エンジンモニタリング、ナビゲーション)、サブシステム別、フィット別、プラットフォーム別、地域別The electronic flight instrument system market is expected to grow from USD 867.9 Million in 2016 to USD 1,139.6 Million by 2021, at a CAGR of 5.60% during the forecast period. Increasing need for lightweight systems with more functionalities and better accuracy, enhanced safety and situational awareness with electronic flight instrument system, and automation of flight controls are factors expect …
- スマートフォン用タッチスクリーンの世界市場:静電容量方式タッチスクリーン、抵抗膜方式タッチスクリーンAbout Touch Screen Touch screen is a two-dimensional sensing device in the form of a transparent sheet, which is integrated on devices and provides a sensing and feedback system. It is a display screen that is sensitive to the touch of a finger or stylus. A touch screen consists of various layers that track and convert movements on the screen into electrical charge in the form of a signal. This si …
- 無人地上車両(UGV)の世界市場予測(~2020)The global UGV market is projected to grow from USD 6.44 Billion in 2015 to USD 18.65 Billion by 2020, at a CAGR of 23.7% during the forecast period. Several factors, such as increasing need of UGVs in commercial applications, rising demand for operational efficiency, and minimized human intervention are expected to be key in driving the UGV market in coming years. On the basis of mode of operatio …
- アメリカのナースコールシステム市場2016-2020About Nurse Call System Market in the USThe NCS helps a caregiver and a patient to effectively communicate with each other and enhance patient care. In the US, individuals undergoing treatment in specialized healthcare facilities such as in SNFs, ALFs, and ACFs need constant attention and care. Hence, to provide 24/7 care to them, there is a need for a dedicated line of communication between patie …
- データストレージ用レーザデバイスの世界市場About Lasers Lasers (light amplification by stimulated emission of radiation) are devices that produce a concentrated beam of coherent monochromatic electromagnetic radiation by stimulated emission of photons from excited molecules. These devices are widely used in applications such as communications, material processing, excimer lithography, data storage, medical and aesthetic, scientific and mil …
- 生物製剤コールドチェーン包装の世界市場About biopharmaceutical cold chain packaging Packaging of products is the process of enclosing them for the purpose of their distribution, storage, sale, and use. Packaging also helps advertise a product in a better way and protect it from damage during transportation. Biopharma products are called as biological medical products, such as blood or blood components, vaccines, and tissues. These prod …
- 硬質プラスチック製食品トレーの世界市場2019-2023About this market With the increasing health and environmental concerns due to the high use of plastics, the bio-based plastics are increasingly being used for manufacturing foodservice disposables. Over the years, several types of bioplastics have emerged and is available in the market. For instance, Polylactide (PLA) is a biodegradable and bioactive thermoplastic aliphatic polyester, which is pr …
- Canadian Natural Resources Limited:石油・ガスバリューチェーン分析レポート2013Canadian Natural Resources Limited Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Canadian Natural Resources Limited" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Canadian Natural Resources Limited”. The report provides key information relating to oil and gas assets of the company along with its operatio …
- ソフトウェアテスト・システムインテグレーションの世界市場About Software Testing System Integration Software testing is one of the important aspects of software development and is a process of analyzing software products to identify the correctness, security, and quality of developed and purchased software. With the number of large projects and involvement of various teams associated in the development process, the complexity of software development and …
- クロストリジウム検査の世界市場2015The report presents a detailed analysis of the Clostridium diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Clostridium definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments: - Hospitals …
- 統合脅威管理(UTM)のグローバル市場(2014-2018)About Unified Threat Management Unified threat management is a fully integrated network security solution that provides a secure way of establishing a network connection with the host server. Unified threat management can be defined as a hardware or software solution that enables inbound and outbound network traffic protection. It integrates security technologies such as firewalls, virtual private …